Banque Pictet & Cie Sa Sangamo Therapeutics, Inc Transaction History

Banque Pictet & Cie Sa

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 01, 2023	SELL	$1.66 - $3.67 $64,683 - $143,005	-38,966 Reduced 31.2%	85,944 $151,000
Q4 2022 Feb 06, 2023	SELL	$2.77 - $5.07 $109,171 - $199,818	-39,412 Reduced 23.98%	124,910 $0
Q3 2022 Nov 10, 2022	SELL	$4.27 - $6.39 $2,617 - $3,917	-613 Reduced 0.37%	164,322 $805 Million
Q2 2022 Aug 08, 2022	SELL	$3.28 - $6.21 $52,138 - $98,714	-15,896 Reduced 8.79%	164,935 $683,000
Q1 2022 May 04, 2022	BUY	$5.23 - $7.82 $36,604 - $54,732	6,999 Added 4.03%	180,831 $1.05 Million
Q4 2021 Feb 02, 2022	BUY	$7.29 - $10.97 $1.27 Million - $1.91 Million	173,832 New	173,832 $1.3 Million

111

56.7M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $193M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Banque Pictet & Cie Sa, based on Form 13F filings with the SEC.

Stay updated on Banque Pictet & Cie Sa with notifications on news.